These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 595517)

  • 1. [Late results of the treatment of I stage malignant ovarian tumors depending on a number of factors].
    Mar'ina LA
    Vopr Onkol; 1977; 23(11):60-5. PubMed ID: 595517
    [No Abstract]   [Full Text] [Related]  

  • 2. [Conservative operations in malignant I-stage ovarian tumors].
    Mar'ina LA
    Vopr Onkol; 1978; 24(3):64-8. PubMed ID: 206020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysgerminoma. An analysis of 105 cases.
    Asadourian LA; Taylor HB
    Obstet Gynecol; 1969 Mar; 33(3):370-9. PubMed ID: 5776086
    [No Abstract]   [Full Text] [Related]  

  • 4. Dysgerminoma: a review of 158 cases from the Emil Novak Ovarian Tumor Registry.
    Gordon A; Lipton D; Woodruff JD
    Obstet Gynecol; 1981 Oct; 58(4):497-504. PubMed ID: 7279343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ovarian cysts and tumors in childhood].
    Ziszi K; Dénes J; Orley J
    Orv Hetil; 1981 Sep; 122(39):2415-7. PubMed ID: 7322543
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant ovarian tumours in children and adolescents.
    Stasek V; Veselý K; Motlík K
    Neoplasma; 1971; 18(3):299-307. PubMed ID: 5093949
    [No Abstract]   [Full Text] [Related]  

  • 7. [General conservative operation in malignant ovarian tumors of the stage Ia (T1aN0M0)].
    Buchholz K; Richter P; Lotze W
    Zentralbl Gynakol; 1985; 107(3):179-83. PubMed ID: 2984861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical analysis of 57 patients with ovarian dysgerminoma].
    Li YF; Li MD; Wu QL; Liu FY; Li JD; Zou JL; Huang YW
    Ai Zheng; 2002 Jan; 21(1):79-82. PubMed ID: 12500404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian teratomas. Relationship of histologic and ontogenic factors to prognosis.
    Woodruff JD; Protos P; Peterson WF
    Am J Obstet Gynecol; 1968 Nov; 102(5):702-15. PubMed ID: 4176444
    [No Abstract]   [Full Text] [Related]  

  • 10. [Lymph node metastasis in stage I ovarian cancer].
    Jang JH
    Zhonghua Fu Chan Ke Za Zhi; 1992 Nov; 27(6):338-40, 379. PubMed ID: 1300277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors responsible for survival in sex cord stromal tumors of the ovary--an analysis of 376 women.
    Zhang M; Cheung MK; Shin JY; Kapp DS; Husain A; Teng NN; Berek JS; Osann K; Chan JK
    Gynecol Oncol; 2007 Feb; 104(2):396-400. PubMed ID: 17030354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Consideration on prognosis of malignant ovarian tumor and influencing factors].
    Nakayama M; Yamabe T; Jimi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1971 Sep; 23(9):869-72. PubMed ID: 5165752
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics of rare ovarian tumors--possibilities of organ preservation].
    Grischke EM; Wallwiener D; Bastert G
    Zentralbl Gynakol; 1996; 118(6):322-5. PubMed ID: 8768007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is surgical restaging indicated in apparent stage IA pure ovarian dysgerminoma? The MITO group retrospective experience.
    Mangili G; Sigismondi C; Lorusso D; Cormio G; Scollo P; Viganò R; Gamucci T; Candiani M; Pignata S
    Gynecol Oncol; 2011 May; 121(2):280-4. PubMed ID: 21277010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic relevance of soluble interleukin-2 receptors in patients with ovarian tumors.
    Gebauer G; Rieger M; Jäger W; Lang N
    Anticancer Res; 1999; 19(4A):2509-11. PubMed ID: 10470184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical-morphological parallels of malignant ovarian tumours].
    Zurabiani TA; Charkviani LI; Gersamiia GK; Charkviani TL
    Georgian Med News; 2006 Oct; (139):70-3. PubMed ID: 17077473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mixed germ cell tumors of the ovary.
    Gershenson DM; Del Junco G; Copeland LJ; Rutledge FN
    Obstet Gynecol; 1984 Aug; 64(2):200-6. PubMed ID: 6204258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serous borderline ovarian tumors].
    Zipprich K; Albrecht G; Canzler E
    Zentralbl Gynakol; 1985; 107(3):159-68. PubMed ID: 3984570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of lymphadenectomy and survival in stage I ovarian cancer patients.
    Chan JK; Munro EG; Cheung MK; Husain A; Teng NN; Berek JS; Osann K
    Obstet Gynecol; 2007 Jan; 109(1):12-9. PubMed ID: 17197582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-term follow-up of the ovarian malignant teratoma].
    Zhu GZ
    Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):220-3, 253-4. PubMed ID: 8404306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.